Author

Sophia Lichterfeld

Dana-Farber Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alexandra IndegliaiD· 1 shared Amy E. SchadeiD· 1 shared Franziska Michor AiD· 1 shared Karen M. CichowskiiD· 1 shared Simone BrunoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra IndegliaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A mechanistic digital twin model for epigenetic therapy optimization in triple-negative breast cancer

Simone Bruno, Alexandra Indeglia, Sophia Lichterfeld, Amy E. Schade, Karen M. Cichowski, Franziska Michor A

This paper develops a digital twin model to optimize epigenetic therapies in triple-negative breast cancer by simulating treatment responses and identifying effective drug combinations.

bioRxiv · Sep 16, 2026 · PreprintCancer Biology